Results 161 to 170 of about 13,638 (219)

Neoantigen-Encoded Oncolytic Viruses as Personalized Cancer Vaccines. [PDF]

Pharmaceuticals (Basel)
Alkayyal AA.
europepmc   +1 more source

Oncovirus classification and insights into herpes simplex virus, Varicella-Zoster virus. [PDF]

Cancer Cell Int
Ghaemi A, Sadeh S.
europepmc   +1 more source

Oncolytic viruses: A novel therapeutic approach for pancreatic cancer. [PDF]

Mol Ther Oncol
Esteves M, Matos AM, Cruz MT.
europepmc   +1 more source

Induction of abscopal effect combining H101 oncolytic virotherapy with tislelizumab in a patient with advanced hepatocellular carcinoma: a case report. [PDF]

Am J Cancer Res
Ou D, Li Y, Wu J, Ou S, Xie F.
europepmc   +1 more source

Shaping the future one slice at a time: How 3D organotypic tumour slice models are driving drug discovery in ovarian cancer. [PDF]

Transl Oncol
Edwards M, Caruana P, Escar M, Céspedes MV.   +3 more
europepmc   +1 more source

The Emerging Role of Oncolytic Virotherapy in Glioblastoma Management. [PDF]

Cancers (Basel)
Nizamutdinov D, Sentmanat A, Tong J, Qi X, Pan Y, Qi D, Wu E, Huang JH.   +7 more
europepmc   +1 more source

Infectious bursal disease virus (IBDV) as a novel oncolytic virotherapy in glioblastoma. [PDF]

J Immunother Cancer
Tur-Planells V, Bykov Y, Dawodu G, García-Romero N, Izpura-Luis S, Pérez-Rodríguez L, Rius-Rocabert S, Palacín-Aliana I, Arranz-Herrero J, Márquez-Leiva I, Monago-Sanchez A, Del Rio ML, Rodriguez-Barbosa JI, Cano-Ochando J, García-Sastre A, Lozano-Ojalvo D, Nistal-Villan E, Ayuso-Sacido A, Cuadrado-Castano S.   +18 more
europepmc   +1 more source

Cancer viroimmunotherapy platforms based on varicella-zoster virus and cytomegalovirus. [PDF]

Mol Ther
Jiang H, Peng KW, Russell SJ.
europepmc   +1 more source

Oncolytic Virotherapy in Colorectal Cancer: Mechanistic Insights, Enhancer Strategies, and Translational Combinations. [PDF]

Cells
Salameh H, Naseem N, Chattha MA, Ramesh J, Ramy H, Cizkova D, Kubatka P, Büsselberg D.   +7 more
europepmc   +1 more source

Dual-cytokine-armed oncolytic HSV for enhanced tumor immunotherapy. [PDF]

Mol Ther Oncol
Dhital R, Pereira MSF.
europepmc   +1 more source